Towards Clinically Relevant Immune Biomarkers in Myeloproliferative Neoplasms: Methodological Considerations for
1Department of Laboratory, Linping District First People's Hospital, Hangzhou City, Zhejiang, China.
International Journal of Laboratory Hematology
|January 13, 2026
Abstract
No abstract available in PubMed .


